Trial Profile
A Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Dose-response Study to Evaluate the Efficacy and Safety of 2 Fixed Dosages of Paliperidone Extended Release Tablets and Olanzapine, With Open-label Extension, in the Treatment of Patients With Schizophrenia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Apr 2010
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary) ; Paliperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Janssen Research & Development
- 08 Apr 2010 New trial record